Résultats de la recherche - 69 results

Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.

Publication Type: Peer reviewed scientific article Authors: Bray, Freddie; Lortet-Tieulent, Joannie; Znaor, Ariana; Brotons, Maria; Poljak, Mario; M. Arbyn Source: Vaccine, Volume 31 Suppl 7, ...

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

Publication Type: Peer reviewed scientific article Authors: Poljak, Mario; Rogovskaya, Svetlana I; Kesić, Vesna; Bray, Freddie; Berkhof, Johannes; Seme, Katja; Brotons, Maria; Castellsagué, Xavier; ...

Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study.

Publication Type: Peer reviewed scientific article Authors: Stone,M.A.; Charpentier,G.; Kris Doggen; Kuss,O.; Lindblad,U.; Kellner,C.; Nolan,J.; Pazderska,A.; Rutten,G.; Trento,M.; Khunti,K. Source: ...

Palliative care service use in four European countries: a cross-national retrospective study via representative networks of general practitioners.

Alonso; Aprile, Pierangelo Lora; Onwuteaka-Philipsen, Bregje D; Deliens, Luc; EURO IMPACT Source: PLoS One, Volume 8, Issue 12, p.e84440 (2013) Keywords: Age factors Delivery of Health Care Europe Female ...

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

cut-off ASCUS + to detect CIN2 + in both triage of ASCUS and LSIL (relative sensitivity of 1.27 (95% CI 1.16 to 1.39; P value < 0.0001) and 1.23 (95% CI 1.06 to 1.4; P value 0.007), respectively. In ...

The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.

studies, comprising 1,839 ASC- US and 1,887 LSIL cases, were retrieved. The pooled sensitivity and specificity of APTIMA to triage ASC- US to detect underlying CIN3 or worse was 96.2% (95% CI = 91.7-98.3%) ...

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

HC2, GP5 +/6+ PCR (polymerase chain reaction), cobas(®) 4800 PCR (Roche Molecular Systems Inc., Alameda, CA, USA) and Real Time PCR (Abbott Molecular, Des Plaines, IL, USA) can be considered as ...

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.

Guglielmo; Wentzensen, Nicolas; Brotherton, Julia; Qiao, You-Lin; Denny, Lynnette; Bornstein, Jacob; Abramowitz, Laurent; Giuliano, Anna; Tommasino, Massimo; Monsonego, Joseph Source: Int J Cancer, Volume 131, ...

QR code

QR code for this page URL